Heroin Addiction Ripped My Family Apart – a Narconon Trois-Rivieres Recovery
Heroin Addiction Ripped my Family Apart – a Narconon Trois-Rivieres Recovery – Heroin addiction real life testimony of Narconon Trois-Rivieres recovery: Sabrina started using drugs and heroin at a very young age and would later run away from home. “I hated my sister” used to say the addict. Desperate not to give up on their daughter, Sabrinas parents were continually doing what they could to find her. The police would come by her house on a regular basis looking for an updated picture or to say they have found her. Originally from Montreal, Sabrina ran away from everything, and found her self in Toronto, Calgary, and Vancouver, using drugs, shooting heroin while being homeless. Gripping testimony from two sisters finally reunited after 7 years after Sabrina completed the Narconon Trois-Rivieres program. Heroin addiction plagues to many of our youths and young adults today, Sabrina was lucky enough to put an end to her heroin addiction in years 2000 with the help of the Narconon Addiction Treatment Center that is now located in Trois-Rivieres, Quebec, Canada.
Highs and lows of using marijuana
Filed under: drug addiction treatment act 2000
Proponents for legalizing marijuana tout its pain-relieving benefits and use by cancer patients undergoing chemotherapy or radiation treatments; opponents stress that science has yet to prove the drug is safe. It's a bit like the fairytale, … The …
Read more on CNN
Heart devices often approved without comparisons
Filed under: drug addiction treatment act 2000
NEW YORK (Reuters Health) – Many new heart devices, such as valves and stents, are approved for use by the U.S. Food and Drug Administration (FDA) without good studies showing that they offer any benefits beyond existing treatments, according to a new …
Read more on Reuters
SALIX PHARMACEUTICALS, LTD. : Salix Pharmaceuticals Reports 3Q2012 …
Filed under: drug addiction treatment act 2000
In order to understand this potential risk, the Division has communicated that a very large, well-controlled, chronic administration trial will have to be conducted to assess the safety of any mu-opioid antagonist prior to market approval for the …
Read more on 4-traders